This Week in Cardiology

Science Podcast · 342 Episodes · Updated Weekly

Source: podcasts.apple.com

Categories: Hem/Oncs, General Medicine News

Tweets with this article

John Mandrola, MD

. @JMoccoMD Brilliant editorial in NEJM on EVT therapy for medium and distal vessel occlusion. I will discuss on This Week in Cardiology podcast. https://t.co/j6jHuANip1 Such a great lesson in EBM-- on being skeptical about observational data and subgroups from RCTs

The 5th Annual OncoAlert Colloquium

The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!

Gil Morgan February 7, 2025

The Cost of Excellence: Rethinking PPS-Exempt Cancer Centers

How do we balance innovation, financial sustainability, and access to care?

Dr. Nina Niu Sanford February 7, 2025

Hyperferritinemia in Critically Ill Patients* : Critical Care Medicine

ses of hyperferritinemia in a mixed cohort of critically ill patients. Design: Retrospective observational study. Setting: Adult surgical, anesthesiologic, and medical ICUs of a university…

Chris Hillis February 7, 2025

À 103 ans, cet homme est le plus vieux médecin de France

Âgé de 103 ans, un médecin généraliste du Val-de-Marne continue d’exercer sa profession pour combler le manque de médecins dans le secteur.

Nicolas Gendron February 7, 2025

The Use of Historical Controls in Clinical Trials, With Dr Althouse

Podcast Episode · JAMAevidence JAMA Guide to Statistics and Methods · 2025-02-06 · 21m

Dr Henry February 7, 2025

SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers

PURPOSESWOG S1815 was a randomized, open label phase III trial, evaluating gemcitabine, nab-paclitaxel, and cisplatin (GAP) versus gemcitabine and cisplatin (GC) in patients with newly…

Anirban Maitra February 7, 2025

Related Articles